Cargando…

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma

Alternative splicing (AS) is a method of increasing the number of proteins that the genome is capable of coding for, by altering the pre-mRNA during its maturation. This process provides the ability of a broad range of proteins to arise from a single gene. AS events are known to occur in up to 94% o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dlamini, Zodwa, Hull, Rodney, Mbatha, Sikhumbuzo Z, Alaouna, Mohammed, Qiao, You-Lin, Yu, Herbert, Chatziioannou, Aristotelis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186946/ https://www.ncbi.nlm.nih.gov/pubmed/34113176 http://dx.doi.org/10.2147/CMAR.S305464

Ejemplares similares

Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making
por: Mbatha, Sikhumbuzo, et al.
Publicado: (2022)

Esophageal cancer genetics in South Africa
por: Alaouna, Mohammed, et al.
Publicado: (2019)

MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets
por: Marima, Rahaba, et al.
Publicado: (2021)

The role played by alternative splicing in antigenic variability in human endo-parasites
por: Hull, Rodney, et al.
Publicado: (2014)

Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases
por: Dlamini, Zodwa, et al.
Publicado: (2015)

Regulation of alternative splicing in obesity-induced hypertension
por: Dlamini, Zodwa, et al.
Publicado: (2019)

Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers
por: Mthembu, Nonkululeko N, et al.
Publicado: (2017)

Can the HIV-1 splicing machinery be targeted for drug discovery?
por: Dlamini, Zodwa, et al.
Publicado: (2017)

Viral Encoded miRNAs in Tumorigenesis: Theranostic Opportunities in Precision Oncology
por: Hull, Rodney, et al.
Publicado: (2022)

Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency
por: Francies, Flavia Zita, et al.
Publicado: (2021)

Immunosuppressive Signaling Pathways as Targeted Cancer Therapies
por: Setlai, Botle Precious, et al.
Publicado: (2022)

The Catastrophic HPV/HIV Dual Viral Oncogenomics in Concert with Dysregulated Alternative Splicing in Cervical Cancer
por: Marima, Rahaba, et al.
Publicado: (2021)

Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward
por: Alaouna, Mohammed, et al.
Publicado: (2023)

Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities
por: Manabile, Mosebo Armstrong, et al.
Publicado: (2023)

Many Voices in a Choir: Tumor-Induced Neurogenesis and Neuronal Driven Alternative Splicing Sound Like Suspects in Tumor Growth and Dissemination
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets
por: Mbita, Zukile, et al.
Publicado: (2014)

LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities
por: Mabeta, Peace, et al.
Publicado: (2022)

Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities
por: Basera, Afra, et al.
Publicado: (2022)

RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant Progression
por: Dlamini, Zodwa, et al.
Publicado: (2019)

The Role of MicroRNAs in Kidney Disease
por: Mukhadi, Sydwell, et al.
Publicado: (2015)

Efavirenz induces DNA damage response pathway in lung cancer
por: Marima, Rahaba, et al.
Publicado: (2020)

Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer
por: Marima, Rahaba, et al.
Publicado: (2020)

The profiling, identification, quantification and analysis of differentially expressed genes (DEGs) in response to drug treatment in lung cancer
por: Marima, Rahaba, et al.
Publicado: (2021)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers
por: Bhoola, Nimisha H., et al.
Publicado: (2018)

Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies
por: Hull, Rodney, et al.
Publicado: (2020)

Artificial intelligence (AI) and big data in cancer and precision oncology
por: Dlamini, Zodwa, et al.
Publicado: (2020)

Reports of Plant-Derived Nanoparticles for Prostate Cancer Therapy
por: Elbagory, Abdulrahman M., et al.
Publicado: (2023)

Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies
por: Francies, Flavia Zita, et al.
Publicado: (2021)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma
por: Setlai, Botle Precious, et al.
Publicado: (2022)

HIV-Associated Cancer Biomarkers: A Requirement for Early Diagnosis
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Identification of prognostic alternative splicing signature in gastric cancer
por: Wang, Zhiwu, et al.
Publicado: (2022)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Prostate Cancer Disparities and Management in Southern Africa: Insights into Practices, Norms and Values
por: Marima, Rahaba, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ns3d1pqvsvvss6iivjicfe9qhc